Detalhe da pesquisa
1.
Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.
Molecules
; 28(16)2023 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37630292
2.
Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer.
Mol Cancer Ther
; 23(4): 552-563, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030378
3.
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.
Cancer Lett
; 565: 216209, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169162
4.
Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.
Mol Cancer Ther
; 16(8): 1680-1692, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428441